12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Anitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday’s after-market session. The market value of their…
Matinas BioPharma’s LNC Platform For The Delivery Of Small Oligonucleotides Featured In Two Presentations At The ASGCT Annual Meeting
Matinas BioPharma Holdings, Inc. (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that James
In Vivo Efficacy Of Matinas BioPharma’s Oral MAT2203 In Pulmonary Mucormycosis Published In Journal Of Antimicrobial Agents And Chemotherapy
Matinas BioPharma Holdings, Inc. (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers OpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday’s after-market session. The market value of…
Matinas BioPharma FY23 EPS $(0.11) Vs $(0.10) YoY
2023 Financial ResultsRevenue for 2023 was $1.1 million, which was generated from the Company's research collaborations with BioNTech SE and Genentech Inc. This compares with revenue for 2022 of $3.2 million, which was
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share.
Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.
Why Is Inflammatory Focused Matinas BioPharma Stock Trading Higher Today?
Wednesday, Matinas BioPharma Holdings Inc (NASDAQ: MTNB) announced results from a series of in vivo studies demonstrating successful oral delivery of two lipid nanocrystal (LNC)-formulated small single-strand oligonucleotides targeting inflammatory cytokines TNFα and IL-17
Matinas BioPharma Updates on MAT2203 Regulatory and Development Pathway Following Feedback from FDA
Matinas BioPharma Holdings, Inc. (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform technology, announces receipt of
Earnings Scheduled For November 8, 2023
Companies Reporting Before The Bell
• Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Matinas BioPharma Hldgs’s Earnings: A Preview
Matinas BioPharma Hldgs (AMEX:MTNB) is set to give its latest quarterly earnings report on Wednesday, 2023-11-08. Here’s what…